20 June 2013
Keywords: otsuka, buys, pdl, busulfex, 200m, japan, pharmaceutical
Article | 24 December 2007
Japan's Otsuka Pharmaceutical has entered into a definitive agreement to acquire the rights to USA-based PDL BioPharma's IV Busulfex (busulfan),
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 December 2007
19 June 2013
© 2013 thepharmaletter.com